Unlock fully automated cell line production

08-Feb-2023

Thermo Fisher Scientific and Celltrio, a manufacturer of robotics-based solutions for the life sciences industry, have announced their collaboration to bring a fully automated cell culture system to biotherapeutics customers. The collaboration will integrate the Thermo Scientific Momentum ...

more

Expands Specialty Diagnostics Segment with Industry Leader in Oncology Testing for Detection and Monitoring of Multiple Myeloma

03-Nov-2022

Thermo Fisher Scientific Inc. announced that it has entered into a definitive agreement to acquire The Binding Site Group, a global leader in specialty diagnostics, from a shareholder group led by European private equity firm Nordic Capital, in an all-cash transaction valued at £2.25 billion, or ...

more

Scale-up bio-manufacturing facility is expected to open in November 2021

01-Mar-2021

LabCentral, the first-of-its-kind shared laboratory space designed as a launchpad for high-potential biotech startups, announced a total of $22.4 million in sponsorship commitments for LabCentral 238, a fully functional life sciences laboratory with a focus on scale-up bio-manufacturing. Thermo ...

more

Offer price increased

17-Jul-2020

Thermo Fisher Scientific Inc. and QIAGEN N.V. announced that they have entered into an amendment to their acquisition agreement under which Thermo Fisher has commenced a tender offer to acquire all of the ordinary shares of QIAGEN. The amendment provides for an increase from the original offer ...

more

03-Mar-2020

Thermo Fisher Scientific Inc. and QIAGEN N.V. announced that their boards of directors, as well as the managing board of QIAGEN N.V., have unanimously approved Thermo Fisher’s proposal to acquire QIAGEN for €39 per share in cash. The offer price represents a premium of approximately 23% to the ...

more

22-May-2019

Thermo Fisher Scientific Inc. announced that it is investing more than $50 million in its global bioproduction capabilities to provide additional capacity for manufacturing single-use bioprocess container (BPC) systems. Thermo Fisher's single-use technologies are used for critical, sterile ...

more

14-Sep-2018

Thermo Fisher Scientific Inc. has signed a definitive agreement with BD (Becton, Dickinson and Compan), under which Thermo Fisher will acquire BD's Advanced Bioprocessing business. This business combines a strong technical services program with a variety of peptones that enhance cell culture ...

more

New site will support complex clinical research and bring more than 200 new jobs to community

19-Mar-2018

Thermo Fisher Scientific announced it is expanding its footprint in the European Union and investing $35 million in a state-of-the-art pharma services supply chain facility in Rheinfelden (Baden) Germany. Company representatives joined Mayor Eberhardt at the Rheinfelden council meeting to unveil ...

more

31-Aug-2017

Thermo Fisher Scientific has formed the Immuno-Oncology Consortium to drive adoption of highly sensitive, next-generation sequencing (NGS) clinical research panels designed to help identify predictive and prognostic biomarkers associated with cancer immunotherapy. Recognizing this shift toward a ...

more

21-Sep-2016

Thermo Fisher Scientific Inc. announced that it has completed its acquisition of FEI Company, Inc. a manufacturer of high-performance electron microscopy, for $107.50 per share in cash, or a total purchase price of approximately $4.2 billion. The completion of the transaction follows the receipt ...

more